Matthew Wheeler

2PUBLICATIONS
1CO-AUTHORS
Molecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 12, 2019
Idarucizumab for dabigatran reversal: the first 6 months in a tertiary centre.

Matthew Wheeler, Andrew Borrie, Rishi Dookia

Pageof 1

Frequent Collaborators